Blog Post Examines Questions Over Long-Term Safety Of Dengue Fever Vaccine

Humanosphere: Questions hover over Asia’s first dengue vaccination program in Philippines
Humanosphere reporter Lisa Nikolau discusses the launch of a school-based immunization campaign in the Philippines to deliver the Dengvaxia vaccine to prevent dengue fever. She writes, “So far, the program appears to be running without difficulties, but some health professionals are concerned that the vaccine was released before researchers could ensure its long-term safety…” (5/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.